WHO gives emergency use authorization to 2 versions of AstraZeneca COVID-19 vaccine

World Health Organization (WHO) director-general Dr. Tedros Adhanom Ghebreyesus on Monday announced the emergency use listing of two COVID-19 vaccines, both of which are versions of the Oxford AstraZeneca vaccine, to be used by COVAX, which provides vaccines for low- to middle-income countries.

• AstraZeneca backtracks, says it will meet EU supply for Q2 after reporting shortfall
• Where is AstraZeneca’s vaccine? Health Canada says not yet ready to greenlight
• Britain to push for cease-fires in conflict zones to allow for COVID-19 vaccine delivery